Despite industry donations, children with diabetes lack secure, long-term access to insulin

The article discusses the ongoing challenges in ensuring consistent access to insulin for children and young people (CYP) living with type 1 diabetes (T1D) in low- and middle-income countries (LMICs), as outlined in the new report from the Access to Medicine Foundation. Although 11 company-supported initiatives aim to improve access for these populations, their long-term viability remains uncertain due to reliance on donations. 

“Hundreds of thousands of children and young people in low- and middle-income countries face significant barriers to accessing essential insulin, supplies and care for managing type 1 diabetes. While the pharmaceutical industry is engaged in the effort to bridge access gaps, as needs grow, initiatives must prioritise widespread coverage, sustainability and affordability to save lives, The article quotes Claudia Martínez, Director of Research at the Foundation. 

The article reinforces the report’s focus on making insulin more affordable as a key to expanding access. It supports the report’s call to move away from donation-based models and ensuring a focus on long-term, sustainable solutions. By taking such actions to address affordability and product availability, companies can help facilitate the successful transition to government owned T1D care in LMICs.